BeiGene releases figures for Q3 on November 10.
7 analysts are forecasting losses of $3.385 per share as opposed to losses of $5.390 per share in the same quarter of the previous year.
Wall Street is expecting the company to report $596.8 million, an increase of 53.95% over the prior year quarter when the company reported $387.6 million.
Overall, analysts expect an average loss of $12.641 per share for the current fiscal year, compared to $-19.430 per share in the previous year. On average, analysts predict that the company will report annual sales of $2.22 billion.
This story was written by Markets Insider's RoboEddy, which automatically writes these stories based on data provided by our partners.